- Conditions
- Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Cutaneous T-Cell Lymphoma, +23 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Hepatosplenic T-cell Lymphoma
Explore clinical trials studying Hepatosplenic T-cell Lymphoma. Study availability and eligibility vary by location and protocol.
47 public trials
3 recruiting studies
Hepatosplenic T-cell Lymphoma trial results
Recruiting
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
NCT05475925
- Conditions
- Aggressive NK Cell Leukemia, Cutaneous PTCL-NOS (CD8+ or CD56+ and Cytotoxic Marker), Cytotoxic PTCL-NOS (CD8+ or CD56+ and Cytotoxic Marker), +27 more
- Locations
-
- Dren Investigational Site Birmingham, Alabama, United States
- Dren Investigational Site Duarte, California, United States
- Dren Investigational Site Irvine, California, United States
- Dren Investigational Site Redwood City, California, United States
Recruiting
A Registry for People With T-cell Lymphoma
NCT05978141
- Conditions
- Adult T-Cell Leukemia/Lymphoma, Aggressive NK-cell Leukemia, Anaplastic Large Cell Lymphoma, ALK-Positive, +54 more
- Locations
-
- City of Hope Cancer Center (Data collection only) Duarte, California, United States
- UNIVERSITY OF CALIFORNIA SAN DIEGO (Data collection only) San Diego, California, United States
- University of California San Francisco (Data collection only) San Francisco, California, United States
- Stanford University Medical Center (Data collection only) Stanford, California, United States
Active, not recruiting
Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma
NCT03113500
- Conditions
- Adult T-Cell Leukemia/Lymphoma, Anaplastic Large Cell Lymphoma, ALK-Positive, Anaplastic Large Cell Lymphoma, ALK-negative, +26 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Hackensack University Medical Center Hackensack, New Jersey, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
- M D Anderson Cancer Center Houston, Texas, United States
Active, not recruiting
Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency
NCT01787409
- Conditions
- Aggressive Non-Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +40 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
- Mayo Clinic Rochester, Minnesota, United States
NCT02232516
- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +32 more
- Locations
-
- City of Hope Duarte, California, United States
- Yale University New Haven, Connecticut, United States
- Northwestern University Chicago, Illinois, United States
- Weill Cornell Medicine New York, United States
NCT01804166
- Conditions
- Colitis, Colitis, Ulcerative, Colonic Diseases, +15 more
- Locations
-
- Norfolk, Virginia, United States
NCT02168140
- Conditions
- Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin Lymphoma, +40 more
- Locations
-
- Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States
- Abramson Cancer Center Philadelphia, Pennsylvania, United States
NCT02561273
- Conditions
- Anaplastic Large Cell Lymphoma, ALK-Positive, Anaplastic Large Cell Lymphoma, ALK-negative, Enteropathy-Associated T-Cell Lymphoma, +21 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Stanford Cancer Institute Palo Alto, California, United States
- University of Colorado Cancer Center, Anschutz Cancer Pavilion Aurora, Colorado, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
Completed
Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid Malignancies
NCT01523223
- Conditions
- Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), +82 more
- Locations
-
- Stanford University Stanford, California, United States